Advent acquires China's largest medical capsule maker

GS Capsule manufactures a range of capsule types for local and foreign pharmaceutical and healthcare companies, including gelatin, non-gelatin, and enteric capsules. Advent is acquiring the business from Meihua Holdings Group and co-investors.

“This deal plays to Advent’s strong expertise in the healthcare sector, our Asian regional investing and ongoing support of Chinese pharmaceutical and healthcare businesses,” Andrew Li, a managing director and head of Greater China at Advent, said in a statement.

“We look forward to helping GS Capsule grow further and to working closely with its experienced management team to expand the firm’s China and global footprint.”

Advent has invested $9.5 billion in 51 healthcare companies globally since 1990. Recent Asian activity has focused on the Indian pharmaceuticals market, where downstream suppliers are enjoying increased attention from private equity.

In the past two years, Advent has acquired RA Chem Pharma and Bharat Serums and Vaccines, both focused on rudimentary chemicals known as active pharmaceutical ingredients (APIs). Earlier this year, it acquired API supplier ZCL Chemicals, setting up an exit for Morgan Stanley Private Equity.

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Save this article  
• Send to  

• Topics
• South Asia
• Healthcare
• Industrials
• Buyouts
• India
• Advent International
• Pharmaceuticals
• manufacturing